OBJECTIVE To determine the diagnostic value of pre-treatment delta neutrophil index (DNI) before treatment in patients with renal cell carcinoma (RCC) and to compare this marker other routine inflammation markers, such as neutrophil-lymphocyte ratio (NLR) platelet-lymphocyte (PLR). STUDY DESIGN Descriptive study. PLACE AND DURATION OF Department Urology, Kahramanmaras Sutcu Imam University, Tur...
